| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/01/2013 | WO2013112850A1 Anhydrous polymorphs of (2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl) } methyl nitrate and processes of preparation thereof |
| 08/01/2013 | WO2013111108A1 5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors |
| 08/01/2013 | WO2013110152A1 Pharmaceutical compositions containing angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis activators for the treatment of ocular pathological conditions |
| 08/01/2013 | WO2013041967A3 Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism |
| 08/01/2013 | US20130197051 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 08/01/2013 | US20130196995 Combination of brimonidine and timolol for topical ophthalmic use |
| 08/01/2013 | US20130196987 Macrocyclic compounds useful as pharmaceuticals |
| 08/01/2013 | US20130195959 Lyophilized platelet lysates |
| 08/01/2013 | CA2862029A1 Generation of photoreceptors from human retinal progenitor cells using polycaprolactone substrates |
| 07/31/2013 | EP2619203A1 Tricyclic compounds, preparation methods, and their uses |
| 07/31/2013 | EP2618832A2 Composition comprising sod, lutein and zeaxanthin |
| 07/31/2013 | EP2618666A1 Novel dihydropyrimidin-2(1h)-one compounds as neurokinin-3 receptor antagonists |
| 07/31/2013 | CN103228283A Oil-in-water emulsion composition containing difluprednate and tobramycin |
| 07/31/2013 | CN103228275A Methods of treating eye diseases associated with inflammation and vascular proliferation |
| 07/31/2013 | CN103228272A Oral care compositions comprising a quinone and a further antimicrobial agent |
| 07/31/2013 | CN103224956A Type-II adeno-associated virus carrying neuritin genes and application thereof in restoring optic nerve injuries |
| 07/31/2013 | CN103224934A Short interfering ribonucleic acid (siRNA) for oral administration |
| 07/31/2013 | CN103224493A Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity |
| 07/31/2013 | CN103223175A Scar and tissue fibration resistant oligomeric double-stranded nucleotide medicine and its application |
| 07/31/2013 | CN103223094A Medicine for treating cataract |
| 07/31/2013 | CN103223070A Drug composition for treating hypersensitivity and preparation method thereof |
| 07/31/2013 | CN103222974A Protective agent for retinal nerve or optic nerve |
| 07/31/2013 | CN103222952A Stable solution preparation comprising carteolol or hydrochloride thereof |
| 07/31/2013 | CN102671030B Chinese medicinal preparation for curing auricular perichondritis |
| 07/31/2013 | CN102659926B Pc-E polypeptide inhibiting aspergillus fumigatus from adhering to cornea |
| 07/31/2013 | CN102584949B Pc-C polypeptide inhibiting aspergillus fumigatus from adhering to cornea |
| 07/31/2013 | CN102579724B Chinese medicine composition for treating glaucoma |
| 07/31/2013 | CN102370671B Active fraction in lucid ganoderma fruiting body, extracting method, application thereof and preparation |
| 07/31/2013 | CN102283799B Azithromycin gel eye drops and preparation process thereof |
| 07/31/2013 | CN101991111B Drug or heal-care food capable of alleviating visual fatigue |
| 07/31/2013 | CN101861317B Antihistaminic and antiallergic agent and a method for the production thereof |
| 07/30/2013 | US8497304 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 07/30/2013 | US8497283 Autotaxin inhibitors |
| 07/30/2013 | CA2704083C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 07/30/2013 | CA2569530C Thienopyrazole derivative having pde 7 inhibitory activity |
| 07/25/2013 | WO2013108837A1 Pyrazole derivative with tlr inhibiting properties |
| 07/25/2013 | WO2013108644A1 Rebamipide therapeutic agent for allergic conjunctivitis |
| 07/25/2013 | WO2013107910A1 Neurological therapies |
| 07/25/2013 | WO2013107515A1 Eye drop composition |
| 07/25/2013 | WO2013107164A1 Novel indoleamine-2, 3-dioxygenase inhibitor, preparation method therefor and uses thereof |
| 07/25/2013 | WO2013106909A1 Novel peptides and methods and uses thereof for preventing retinal disorders |
| 07/25/2013 | WO2013003114A8 Esters for treatment of ocular inflammatory conditions |
| 07/25/2013 | US20130189341 Generation of photoreceptors from human retinal progenitor cells using polycaprolactone substrates |
| 07/25/2013 | CA2863500A1 Eye drop composition |
| 07/24/2013 | EP2616069A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl]methanol |
| 07/24/2013 | EP2616068A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl]methanol for lowering intraocular pressure |
| 07/24/2013 | EP2616066A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl]methanol for treating retinal diseases |
| 07/24/2013 | CN1795196B Use of amide in preparing compound agent for repairing corneal sensitivity |
| 07/24/2013 | CN103221041A Therapeutic or prophylactic agent for corneal epithelium disorders and/or conjunctival epithelium disorders |
| 07/24/2013 | CN103214555A Peptide inhibitors for mediating stress responses |
| 07/24/2013 | CN103214479A Pyrazole naphthylurea tyrosine kinase inhibitor and its application |
| 07/24/2013 | CN103214478A Pyridineoxopyridazine derivatives |
| 07/24/2013 | CN103214450A Modulators of atp-binding cassette transporters |
| 07/24/2013 | CN103214376A Substituted 4-aminocyclohexane derivatives |
| 07/24/2013 | CN103212088A Antisense compounds targeted to connexins and methods of use thereof |
| 07/24/2013 | CN103212075A Eye drop containing VEGF antagonist |
| 07/24/2013 | CN103211979A New use of dendrobium officinale kimura et migo in diabetic complication prevention and treatment |
| 07/24/2013 | CN103211969A Traditional Chinese medicine for treatment of myopia |
| 07/24/2013 | CN103211942A Chinese medicament for treating acute conjunctivitis |
| 07/24/2013 | CN103211913A Traditional Chinese medicine composition for preventing or treating hypopsia and preparation method thereof |
| 07/24/2013 | CN103211869A Traditional Chinese medicine eye drops used for treating acute conjunctivitis and preparation method thereof |
| 07/24/2013 | CN103211755A Production method of sterile stable azithromycin eye drops |
| 07/24/2013 | CN103211754A Production method of sterile stable pirenoxine sodium eye drops |
| 07/24/2013 | CN102671052B Chinese medicinal composition for treating Meniere's syndrome |
| 07/24/2013 | CN102614331B Chinese medicinal preparation for treating tinnitus and deafness |
| 07/23/2013 | US8492560 Quinazoline derivatives as angiogenesis inhibitors |
| 07/23/2013 | US8492416 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/23/2013 | US8492389 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/23/2013 | US8491931 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine |
| 07/23/2013 | US8491912 Methods of treating ocular and other diseases with Syn-134R polypeptide |
| 07/23/2013 | US8491905 KLK-13 antibody inhibitor for treating dry eye |
| 07/23/2013 | CA2717679C Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 07/23/2013 | CA2681850C Styrenyl derivative compounds for treating ophthalmic diseases and disorders |
| 07/23/2013 | CA2599348C Indole compound and use thereof |
| 07/23/2013 | CA2357950C Therapeutic phosphodiesterase inhibitors |
| 07/18/2013 | WO2013106565A1 Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide f2 alpha agonists |
| 07/18/2013 | WO2013106494A1 Combination therapy for treating hearing and balance disorders |
| 07/18/2013 | WO2013106230A1 Otic formulations, methods and devices |
| 07/18/2013 | WO2012076684A8 Dosages of arylsulfonamide derivatives |
| 07/18/2013 | US20130184333 Growth factor isoform |
| 07/18/2013 | US20130181107 Furnace mount and method of installation |
| 07/17/2013 | EP2614860A2 Pharmaceutical composition for the treatment of dry eye |
| 07/17/2013 | EP2614838A1 Agent for treatment of dry eye characterized by combining p2y² receptor agonist with hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y² receptor agonist and hyaluronic acid or salt thereof |
| 07/17/2013 | EP2613795A2 Treatment of diseases |
| 07/17/2013 | CN103209694A Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases |
| 07/17/2013 | CN103205410A Recombinant microplasmin, its preparation method and application |
| 07/17/2013 | CN103205407A Extended soluble ph20 polypeptides and uses thereof |
| 07/17/2013 | CN103204852A Heteroaryl amide analogues as P2X7 antagonists |
| 07/17/2013 | CN103204827A Benzothiadiazole compounds as protein kinase inhibitors, and preparation method and application thereof |
| 07/17/2013 | CN103204825A Benzothiazole compounds as protein kinase inhibitors, and preparation method and application thereof |
| 07/17/2013 | CN103204822A Benzoxazole compounds as protein kinase inhibitors, and preparation method and application thereof |
| 07/17/2013 | CN103204813A Condensed imidazole derivatives as TRPV3 antagonist |
| 07/17/2013 | CN103202959A Powder for treating suppurative otitis media by using Berberis kawakamii Hayata |
| 07/17/2013 | CN103202954A Dendrobium nobile oral liquid for improving eyesight |
| 07/17/2013 | CN103202925A Medicine for treating hordeolum and preparation method thereof |
| 07/17/2013 | CN103202833A Pharmaceutical composition of olopatadine or salts of olopatadine, and preparation method thereof |
| 07/17/2013 | CN103202817A Preparation method for mannitol grains capable of being directly pressed |
| 07/17/2013 | CN102836124B Dibazol hydrochloride eye drops and preparation method thereof |
| 07/17/2013 | CN102526132B Antifungal ear drops |
| 07/17/2013 | CN102512589B Medicine for treating early sudden deafness |